Stock Comparison
DXCM vs SYK
DexCom Inc and Stryker Corporation side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$27.07B
$127.55B
P/E (TTM)
30.1
38.5
Forward P/E
26.8
22.2
Price/Sales
5.6
5.1
Price/Book
9.0
5.6
EV/EBITDA
17.2
21.6
Dividend Yield
—
1.09%
Profitability
Net Margin
19.30%
13.20%
Operating Margin
21.40%
17.80%
Return on Equity
35.60%
15.20%
Return on Assets
9.65%
7.72%
Growth (YoY)
Revenue Growth
15.00%
2.60%
Earnings Growth
92.20%
14.20%
Price & Risk
Beta
1.4
0.8
52-Week High
$89.98
$401.86
52-Week Low
$54.11
$281.00
Analyst Target
$85.24
$386.80
Compare DXCM and SYK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.